BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to...
As Australia marks Scam Awareness Week, organisations are being urged to rethink their approach to scam prevention ...
Despite years of investment in digital engagement, from rolling out mobile apps and online portals to digital communication...
ByronBay.au, TheCairnsTimes.com.au, AirlieTimes.com.au and NoosaTimes.com have been launched as part of an expanding networ...
Nikon is developing a new series of nine NIKKOR Z CINEMA T1.9 VV cinema lenses, designed for cinem...
A small-batch concrete delivery service which has fast established itself as an integral player in...
Nikon is developing a new series of nine NIKKOR Z CINEMA T1.9 VV cinema lenses, designed for cinem...
“All the world's a stage.” Shakespeare wasn't writing about Cairns when he penned that famous lin...
A small-batch concrete delivery service which has fast established itself as an integral player in...
A leading dental expert is warning that some of the most popular wellness trends could be damaging...
The conflict around Iran and the Strait of Hormuz has entered a more dangerous phase, with the Uni...